Private equity firm Altus Capital Partners has acquired specialised spinal implants manufacturer ChoiceSpine for an undisclosed sum.
ChoiceSpine also designs and markets instrumentation and biologics for the surgical treatment of complex spine disorders.
ChoiceSpine and Knox Spine develop new products in collaboration with physicians. Products incorporate existing medical technology with customised patient solutions.
Altus Capital Partners co-founder and senior partner Gregory Greenberg said: “We recognise the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients.
“ChoiceSpine, a global medical device corporation specialising in innovative solutions for both spinal fusion hardware and biologics, demonstrates a track record of proven innovation, strong sales growth, increased distribution and the necessity of their products in the marketplace.”
The company’s management will continue to invest in the expansion of the business.
The latest deal is said to be Altus’s second acquisition in the medical technology space.
In December last year, the company completed the tender offer to acquire all of the outstanding shares of common stock of global medical technology company dedicated to cardiorespiratory health solutions, MGC Diagnostics.
ChoiceSpine founder Marty Altshuler said: “We look forward to working with Altus in further developing our offerings as well as expanding into new product verticals to continue to grow the company and provide patient solutions for the treatment of spinal disorders.”
ChoiceSpine manufactures minimally invasive, cervical, thoracolumbar, interbody, lateral, and biologics kits and implants.